p53 and prognosis in colorectal cancer.
The p53 tumour suppressor gene is found altered in the majority of colorectal adenocarcinomas. While these changes are believed to reflect underlying mechanisms of tumour development and progression, it is becoming increasingly clear that such changes may also reflect the macroscopic biological behaviour of the course of the disease. Knowledge of the p53 tumour suppressor gene status may therefore provide important prognostic information. This review examines some of the data that are beginning to show that p53 tumour suppressor gene status may be an important prognostic indicator.
Smith
D R
DR
Department of Colorectal Surgery, Singapore General Hospital, Singapore.
Goh
H S
HS
D000230:Adenocarcinoma / Q000235:genetics* / Q000401:mortality / Q000628:therapy; D017209:Apoptosis; D014408:Biomarkers, Tumor / Q000235:genetics; D015179:Colorectal Neoplasms / Q000235:genetics* / Q000401:mortality / Q000628:therapy; D016158:Genes, p53 / Q000502:physiology; D006801:Humans; D017354:Point Mutation; D011379:Prognosis
D014408:Biomarkers, Tumor